VACCINATING GUINEA-PIGS WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS IN AN EFFICACIOUS ADJUVANT FORMULATION ELICITS PROTECTION AGAINST VAGINAL INFECTION
Ne. Byars et al., VACCINATING GUINEA-PIGS WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS IN AN EFFICACIOUS ADJUVANT FORMULATION ELICITS PROTECTION AGAINST VAGINAL INFECTION, Vaccine, 12(3), 1994, pp. 200-209
Guinea pigs were immunized with glycoprotein gD-2t in SAF-m or saline,
then challenged with herpes simplex virus, type 2 (HSV-2). Animals gi
ven gD-2t in SAF-m had higher anti-gD-2t antibodies, fewer and less se
vere vaginal lesions, and decreased ganglionic latency compared to ani
mals given gD-2t in saline. Leucocytes from animals vaccinated with gD
-2t in SAF-m had greater proliferative responses to gD-2t in vitro tha
n cells from control animals. MHC II-restricted, gD-2t-specific cytoto
xic T cells were induced in guinea pigs vaccinated with gD-2t in SAF-m
. Thus, immunization of guinea pigs with gD-2t in SAF-m markedly reduc
ed the incidence and severity of primary, HSV-2 by eliciting both humo
ral and cell-mediated responses.